Skip to Main Content

Advertisement

American Association for Cancer Research Logo
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 3, Issue 4
1 April 2004
Molecular Cancer Therapeutics Cover Image for Volume 3, Issue 4
All Issues
ISSN 1535-7163
EISSN 1538-8514
Issue Sections

ARTICLE

Development of a high-throughput screen for inhibitors of replication protein A and its role in nucleotide excision repair
Brooke J. Andrews; John J. Turchi
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Homologous recombination is a highly conserved determinant of the synergistic cytotoxicity between cisplatin and DNA topoisomerase I poisons
Robert C.A.M. van Waardenburg; Laurina A. de Jong; Foke van Delft; Maria A.J. van Eijndhoven; Melanie Bohlander; Mary-Ann Bjornsti; Jaap Brouwer; Jan H.M. Schellens
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
N′-(phenyl-pyridin-2-yl-methylene)-hydrazine carbodithioic acid methyl ester enhances radiation-induced cell death by targeting Bcl-2 against human lung carcinoma cells
Jong Kuk Park; Young Min Chung; Byung-Gyu Kim; Young-A Yoo; Beom-Seok Yang; Jun Suk Kim; Young Do Yoo
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of γH2AX foci
Kevin Camphausen; Kristin J. Brady; William E. Burgan; Michael A. Cerra; Jeffery S. Russell; Elizabeth E.A. Bull; Philip J. Tofilon
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Cyclooxygenase (COX)-2-dependent effects of the inhibitor SC236 when combined with ionizing radiation in mammary tumor cells derived from HER-2/neu mice
Susan Lanza-Jacoby; Adam P. Dicker; Sheldon Miller; Francis E. Rosato; John T. Flynn; Stephanie N. Lavorgna; Randy Burd
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells
Xu Dong Zhang; Susan K. Gillespie; Jodie M. Borrow; Peter Hersey
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures
N. Sanjib Banerjee; Angel A. Rivera; Minghui Wang; Louise T. Chow; Thomas R. Broker; David T. Curiel; Dirk M. Nettelbeck
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer
Sangeeta Rojanala; Haiyong Han; Rubén M. Muñoz; Walden Browne; Raymond Nagle; Daniel D. Von Hoff; David J. Bearss
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy
Afshin Dowlati; David Nethery; Jeffrey A. Kern
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation
Mayumi Ono; Akira Hirata; Takuro Kometani; Miho Miyagawa; Shu-ichi Ueda; Hisafumi Kinoshita; Teruhiko Fujii; Michihiko Kuwano
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2
Takayuki Ikezoe; Tsuyako Saito; Kentaro Bandobashi; Yang Yang; H. Phillip Koeffler; Hirokuni Taguchi
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
In vivo tumor imaging in mice with near-infrared labeled endostatin
Deborah Citrin; Andrew K. Lee; Tamalee Scott; Mary Sproull; Cynthia Ménard; Philip J. Tofilon; Kevin Camphausen
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Induction of endoplasmic reticulum stress by ellipticine plant alkaloids
Maria Hägg; Maria Berndtsson; Aleksandra Mandic; Rong Zhou; Maria C. Shoshan; Stig Linder
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression
Stephen Swenson; Fritz Costa; Radu Minea; Russell P. Sherwin; William Ernst; Gary Fujii; Dongyun Yang; Francis S. Markland, Jr.
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Minireview

G2 checkpoint abrogators as anticancer drugs
Takumi Kawabe
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Advertisement

Latest News
AI Model Could Make Cachexia Detection Easier
Drugging WRN: Clinical Proof-of-Concept Established
Using Liquid Biopsy to Guide Adjuvant ICI for dMMR Tumors
View more recent articles
Breaking
Treatment for Rare Ovarian Tumors Gets Greenlight
First At-Home Cervical Cancer Screening Test OK’d in U.S.
Trump Picks New Surgeon General
View more recent articles
Research Watch
ROS Sensing Regulates Mitochondrial Translation and Chemotherapy Response
Dietary Fat Promotes Triple-Negative Breast Cancer through FABP5–mTOR
Ligand Engagement Induces LAG3 Checkpoint Activity through Ubiquitination
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck.  None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept